1. Pink Sheet
  2. >>Geography
  4. >>Japan

Japan’s Drug Distribution Crisis: Pharma Urges Govt To Reform Pricing System

Low Prices Seen Part Of Wider Problem

 
• By Lisa Takagi

The impact of drug shortages in Japan, including of essential products, is being considered as part of government-level discussions to consider the appropriateness of the current reimbursement pricing system. Amid rising production costs and wider global challenges, some experts in the industry are now asking for price increases.

Japanese pharmaceutical firms and associations have urged the government to reform the pricing review system in recent discussion
Japanese pharma industry urges government to reform pricing system to ensure stable supplies • Source: Shutterstock

The Japanese government is continuing to discuss how to stabilize the domestic supply of drugs, which has now been affected by multiple factors for several years.

Both internal and external elements, such as the country’s "generic crisis" and more frequent drug pricing reviews and cuts, along with rising distribution costs triggered by the Ukraine crisis, are having an ultimate

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

Japan Looks To Build Domestic Capacity In New Modalities

 
• By Lisa Takagi

Japan's trade ministry is providing new support to build domestic capacity for new modalities including cell and gene therapies, as part of wider efforts to support the national bioventure ecosystem.

Japan Identifies Drugs ‘In Urgent Need’ Of Development

 
• By Lisa Takagi

Artesunate for malaria, TB drug pretomanid and omadacycline for pneumonia and skin infections are among the drugs identified by Japanese regulatory authorities in urgent need of domestic development.

Japan Pushes Generic Industry Reforms Via New Govt Fund

 
• By Lisa Takagi

Amid ongoing generic drug supply problems, Japan's government is to set up a new fund to support corporate investments geared towards manufacturing and consolidation.

Japan Expands Priority R&D List For Regular Vaccinations

 
• By Lisa Takagi

Japan adds four new pediatric vaccines, including for MMRV and norovirus, to a list of priority vaccines eligible for assistance in regulatory processing.

More from Asia